Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidanc...(es includes i) $238.8 and $111.7 of ...)

incremental tax benefit in 2007 and 2006, respectively, for the pre-

tax reconciling items between GAAP and adjusted net income; ii) in

2007, $31.9 of incremental tax benefit from adjusting the company's

deferred tax balances as a result of newly enacted tax rates in the

United Kingdom, Denmark, Germany and Canada; and iii) in

2006, $1.2 of incremental tax provision for the estimated effect of

tax audits of prior years in a non-U.S. country.

(i) Consolidated depreciation expense in 2007 and 2006 is $185.7 and

$69.9, respectively.

(j) Consolidated equity compensation expense included in both reported and

adjusted results is $51.1 and $32.6 in 2007 and 2006, respectively,

aside from the 2006 charge discussed in note (e).

(k) Pro forma results combine the results of the company with the pre-

merger results of Fisher Scientific International Inc. Equity

compensation expense of $74.7 is included in the pro forma 2006

results.

Note: Consolidated net capital expenditures in 2007 totaled $156.3.

Condensed Consolidated Balance Sheet

(In millions) Dec. 31, 2007 Dec. 31, 2006

Assets

Current Assets:

Cash and cash equivalents $636.2 $667.4

Short-term investments 14.1 23.8

Accounts receivable, net 1,450.0 1,392.7

Inventories 1,169.9 1,164.5

Other current assets 408.9 411.1

Total current assets 3,679.1 3,659.5

Property, Plant and Equipment, Net 1,267.4 1,256.7

Acquisition-related Intangible Assets 7,157.8 7,511.6

Oth
'/>"/>